Michael D. Coffey
Papers
1
Total Citations
53
H-Index
1
About
Michael D. Coffey is a leading figure in radiation oncology, with a focused expertise in stereotactic radiosurgery and the management of brain metastases. His major contributions center on optimizing postoperative radiation protocols, particularly through the use of hypofractionated stereotactic brain radiation (HSRT). In his highly cited 2018 study, Coffey demonstrated that delivering higher biologically effective doses (BED10) via HSRT significantly improves local control for patients with resected brain metastases. This work, which has garnered over 50 citations, has directly influenced clinical practice by providing a refined framework for balancing tumor control with normal tissue toxicity. Coffey’s research is notable for its rigorous dosimetric analysis and its practical implications for improving patient outcomes in a challenging oncologic setting. His contributions have helped establish HSRT as a cornerstone of postoperative management, earning him recognition as a key innovator in the field. For students and researchers, Coffey’s work exemplifies how translational research can bridge the gap between radiobiological principles and tangible clinical benefit.
Research Focus
Key Achievements
Top Papers
- 1